Angioimmunoblastic T-cell lymphoma: treatment strategies and prognostic factors from a retrospective multicenter study in China-Reference-Cited by-同舟云学术

Angioimmunoblastic T-cell lymphoma: treatment strategies and prognostic factors from a retrospective multicenter study in China

Published:2021-12-27 Issue: Volume: Page:1-8
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Zhang Chen¹,Mi Lan¹,Wu Meng¹,Liu Weiping¹,Ma Hongmei²,Ren Jianxin²,Zhao Linjun³,Wang Xiaopei¹,Song Yuqin¹,Zhu Jun¹

Affiliation:

1. Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Lymphoma, Peking University Cancer Hospital & Institute, Beijing, China

2. Department of Hematology, Cangzhou People’s Hospital, Cangzhou, China

3. Department of Lymphoma, Peking University International Hospital, Beijing, China

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2021.2015586

Reference19 articles.

1. Clinicopathologic Characteristics of Angioimmunoblastic T-Cell Lymphoma: Analysis of the International Peripheral T-Cell Lymphoma Project

2. Angio-immunoblastic lymphadenopathy

3. Angioimmunoblastic T-Cell Lymphoma

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Involvement of spleen is associated with shorter survival in patients with angioimmunoblastic T cell lymphoma;Journal of Cancer Research and Clinical Oncology;2023-05-27

2. Genetic abnormalities assist in pathological diagnosis and EBV-positive cell density impact survival in Chinese angioimmunoblastic T-cell lymphoma patients;Chinese Journal of Cancer Research;2023

3. Ofeleein i mi Vlaptin—Volume II: Immunity Following Infection or mRNA Vaccination, Drug Therapies and Non-Pharmacological Management at Post-Two Years SARS-CoV-2 Pandemic;Medicina;2022-02-17